IDiyas

For the Inventor, By the Inventor

Paris, France

Biomunex Pharmaceuticals


USPTO Granted Patents = 4



Trademarks = 1

Forward Citations = 1

Loading Chart...
Loading Chart...

13 inventors (with patents filed for the assignee):

goldMedal Eugene Alexander Zhukovsky (3 out of 9 patents)

silverMedal Olivier Leger (2 out of 21 patents)

bronzeMedal Richard J Morse (2 out of 2 patents)

4.  Olivier Leger (2 out of 2 patents)

5.  Christel Larbouret (1 out of 9 patents)

6.  Andre Pelegrin (1 out of 8 patents)

7.  Pierre-emmanuel Gerard (1 out of 1 patent)

8.  Eugene Zhukovsky (1 out of 1 patent)

9.  André Pelegrin (7 patents)

10.  Richard J Morse (0 patent)


4 patents:

1. 12054550 - Bispecific antibodies targeting EGFR and HER2 (2024-08-06),
2. 11958913 - Polypeptide linker for preparing multispecific antibodies (2024-04-16),
3. 11560437 - Stable multispecific antibodies (2023-01-24),
4. 11505616 - Binding molecules to CD38 and PD-L1 (2022-11-22),
Biomunex Pharmaceuticals is a biotechnology company focused on developing next-generation antibody-based therapeutics for the treatment of various diseases. The company's innovative platform allows for the rapid discovery and optimization of highly potent antibodies with improved properties and reduced side effects. Biomunex is committed to advancing the field of antibody therapeutics and improving the lives of patients worldwide.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

4 Patents

#609 in Paris

#3,284 in France

...
Paris, France

Biomunex Pharmaceuticals

Forward Citations = 1

13 inventors:

goldMedal Eugene Alexander Zhukovsky (3 out of 9 patents)

silverMedal Olivier Leger (2 out of 21 patents)

bronzeMedal Richard J Morse (2 out of 2 patents)

4.  Olivier Leger (2 out of 2 patents)

5.  Christel Larbouret (1 out of 9 patents)

Please report any incorrect information to support@idiyas.com
Loading…